Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/15/17 → 11/20/19 |
Funding
- Janssen Research and Development LLC: $105,455.00
A Phase 2b /3 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects who are Asymptomatic at Risk for Developing Alzheimer's Protocol 54861911ALZ2003
- Jicha, Gregory (PI)
- Caban-Holt, Allison (CoI)
- Murphy, Richard (CoI)